Body image disturbances in AYA cancer patients confronting infertility risk and fertility preservation decisions – Nina Jackson Levin

Pink Sari Inc is run by a dynamo of female community leaders from diverse language groups from the Indian sub-continent – Tracey O’Brien

Zenocutuzumab has rec’d Breakthrough Designation (BTD) from US FDA for NRG1+ NSCLC – Debyani Chakravarty

Big shout out to Conquer Cancer, the ASCO Foundation for supporting young researchers from all over the world – Akhil Santhosh

Bereavement is likely not in the curricula for oncology fellows this July, maybe not at all over 3 years. It should be – Ramy Sedhom

Heteroleptic bipyridine PdII-Bian complexes were cytotoxic in a low micromolar concentration range and demonstrated some selectivity toward cancer cells compared to noncancerous MRC-5 lung fibroblasts – Jemma Arakelyan

KN495 updated clinical manuscript entitled “Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results” has been epublished by Nature Medicine on July 10

Get involved with Common Sense Oncology – Aaron Goodman

Paediatric Cancer Nurses – Survey

The future is definitely bright – Matteo Lambertini